Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 1)

v3.22.1
STOCKHOLDERS EQUITY (DEFICIT) (Details 1) - 2019 Stock Incentive Plan
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Number Of Options Outstanding 1,611,574
Weighted Average Remaining Contractual Life (in Years) 8 years 2 months 8 days
Number Of Exercisable Options 977,457
Weighted Average Exercise Price Exercisable | $ / shares $ 8.13
4.00-4.99  
Number Of Options Outstanding 53,324
Weighted Average Remaining Contractual Life (in Years) 9 years 6 months 14 days
Number Of Exercisable Options 13,331
Weighted Average Exercise Price Exercisable | $ / shares $ 4.48
Exercise Price Range 4.00-4.99
5.00-5.99  
Number Of Options Outstanding 814,500
Weighted Average Remaining Contractual Life (in Years) 9 years 7 months 17 days
Number Of Exercisable Options 339,125
Weighted Average Exercise Price Exercisable | $ / shares $ 5.50
Exercise Price Range 5.00-5.99
8.00-8.99  
Number Of Options Outstanding 375,000
Weighted Average Remaining Contractual Life (in Years) 7 years 4 months 6 days
Number Of Exercisable Options 371,876
Weighted Average Exercise Price Exercisable | $ / shares $ 8.05
Exercise Price Range 8.00-8.99
11.00-11.99  
Number Of Options Outstanding 175,000
Weighted Average Remaining Contractual Life (in Years) 8 years 8 months 4 days
Number Of Exercisable Options 81,250
Weighted Average Exercise Price Exercisable | $ / shares $ 11.20
Exercise Price Range 11.00-11.99
12.00-12.99  
Number Of Options Outstanding 168,750
Weighted Average Remaining Contractual Life (in Years) 2 years 10 months 20 days
Number Of Exercisable Options 146,875
Weighted Average Exercise Price Exercisable | $ / shares $ 12.80
Exercise Price Range 12.00-12.99
9.00-9.99  
Number Of Options Outstanding 25,000
Weighted Average Remaining Contractual Life (in Years) 3 years 4 months 17 days
Number Of Exercisable Options 25,000
Weighted Average Exercise Price Exercisable | $ / shares $ 9.60
Exercise Price Range 9.00-9.99